1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow CMP Development, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients Spironolactone Oral Suspension - Edema Due to Heart Failure or Cirrhosis | Phase 4 | Not yet recruiting | CMP Development, LLC | 96 | 2027-06-01 | 2026-10-22 |
| Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug) Digoxin 250 MCG Oral Tablet, Spironolactone 25 mg/ 5 mL S/F Suspension - Drug Drug Interaction | Phase 1 | Completed | CMP Development, LLC | 28 | 2019-03-10 | 2023-05-01 |
Fibrosis (1)
Canrenoic Acid (1) · Digoxin (1) · Spironolactone (1) · Tablets (1)
India (1)
Gerald Sakowski (1) · Roopali K Somani, MD (1)